Opthea to Present at Needham Healthcare Conference
Ticker: OPTEY · Form: 6-K · Filed: Apr 5, 2024 · CIK: 1815620
Sentiment: neutral
Topics: conference-participation, healthcare, biotech
TL;DR
Opthea is presenting at the Needham Healthcare Conference, expect updates on their eye disease drugs.
AI Summary
Opthea Limited announced on April 5, 2024, that it will participate in the 23rd Annual Needham Virtual Healthcare Conference. The company will present its latest corporate and clinical developments regarding its novel biologic therapies for the treatment of eye diseases.
Why It Matters
Participation in industry conferences allows Opthea to update investors and the medical community on its progress, potentially influencing its stock valuation and future funding opportunities.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in a conference, which is routine and does not involve significant financial or operational changes.
Key Players & Entities
- Opthea Limited (company) — Registrant
- Needham Virtual Healthcare Conference (company) — Event Host
- April 5, 2024 (date) — Filing Date
- 23rd Annual (event_detail) — Conference Edition
FAQ
What is the purpose of this 6-K filing?
This 6-K filing is to report that Opthea Limited will participate in the 23rd Annual Needham Virtual Healthcare Conference.
When was this report filed?
This report was filed on April 5, 2024.
What is Opthea Limited's primary business?
Opthea Limited is in the business of Biological Products (No Diagnostic Substances).
Where is Opthea Limited's principal executive office located?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
What exhibit is included with this filing?
Exhibit 99.1 is included, which is a Press Release announcing Opthea's participation in the 23rd Annual Needham Virtual Healthcare Conference.
Filing Stats: 153 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2024-04-04 18:34:37
Filing Documents
- opt_needham.htm (6-K) — 23KB
- opt-ex99_1.htm (EX-99.1) — 20KB
- img260626642_0.jpg (GRAPHIC) — 61KB
- img260626642_1.jpg (GRAPHIC) — 61KB
- 0000950170-24-041959.txt ( ) — 212KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 04/05/2024